Intellectual Property India Publishes Patent Application for 'Glycoprotein D Variants As Vaccine Adjuvants' Filed by Virion Therapeutics, Llc; and The Wistar Institute

MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517074236 A) filed by Virion Therapeutics, Llc; and The Wistar Institute, Newark, U.S.A., on Aug. 4, for 'glycoprotein d variants as vaccine adjuvants.'

Inventor(s) include Ertl, Hildegund CJ; Currie, Sue L; and Luber, Andrew D.

The application for the patent was published on Aug. 22, under issue no. 34/2025.

According to the abstract released by the Intellectual Property India: "Disclosed herein are compositions for increasing the immunogenicity of a vaccine antigen and methods of inducing an immune response in a subject using the compositions described herein. Disclosed herein are compositions for a therapeutic vaccine to HPV- associated cancer...